Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
In Thousands, except Share data
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2013 $ 6,512 $ 0 $ 6 $ 33,235 $ (1) $ (26,728)
Balance (in shares) at Dec. 31, 2013   0 5,834,081      
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) 5,358 0 1 5,357 0 0
Issuance of common stock in exchange for exercise of warrants ($4.25 per share) (in shares)   0 1,260,734      
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 40,654 0 3 40,651 0 0
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 (in shares)   0 2,898,550      
Issuance of common stock in July 2014 ($11.90 per share) net of transaction expenses of $636 7,182 0 1 7,181    
Issuance of common stock in July 2014 ($11.90 per share) net of transaction expenses of $636 (in shares)   0 657,000      
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) 608 0 0 608   0
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) (in shares)   0 50,000      
Issuance of common stock in exchange for 48,240 warrants exercised on a cashless basis 0 0 0 0 0 0
Issuance of common stock in exchange for 48,240 warrants exercised on a cashless basis (in shares)   0 33,678      
Stock based compensation 2,088 0 0 2,088 0 0
Foreign currency translation adjustment 2 0 0 0 2 0
Net loss (18,627) 0 0 0 0 (18,627)
Balance at Sep. 30, 2014 $ 43,777 $ 0 $ 11 $ 89,120 $ 1 $ (45,355)
Balance (in shares) at Sep. 30, 2014   0 10,734,043